Android app on Google Play

Sangamo Biosciences, Inc. (SGMO) Tops Q4 EPS by 5c, Guides FY Rev

February 6, 2013 4:10 PM EST Send to a Friend
Sangamo Biosciences, Inc. (NASDAQ: SGMO) reported Q4 EPS of ($0.07), $0.05 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $8.9 million versus the consensus estimate of $5.95 million.

Sangamo Biosciences, Inc. sees FY2013 revenue of $20-24 million, versus the consensus of $23.09 million.

For earnings history and earnings-related data on Sangamo Biosciences, Inc. (SGMO) click here.




You May Also Be Interested In


Related Categories

Earnings, Guidance

Related Entities

Earnings

Add Your Comment